Dr. George Magrath, Chief Executive Officer of Opus Genetics, Inc.

Opus Genetics, Inc., a clinical-stage gene therapy company developing treatments for inherited retinal diseases (IRDs) and broader ophthalmic conditions.

Format

PNG

Source

PRISM MarketView

Dr. George Magrath, Chief Executive Officer of Opus Genetics, Inc.

Format

Source

Downloads